CGRP Inhibitors Market to Reach US$12.5 Bn by 2033 Expands with Rising Migraine Awareness and Advanced Targeted Therapies - Persistence Market Research

Keyword: Dysphagia

Publisher: PRNewswire

Published: May 25, 2026

LONDON, May 25, 2026 /PRNewswire/ -- The global CGRP inhibitors market is expanding rapidly, expected to be valued at around US$ 6.5 billion in 2026 and projected to reach US$ 12.5 billion by 2033, w… [+13498 chars]

Read Full Story ↗

Related Content

Related Story Meeting the Aged Care Quality Standards – Food and nutrition

Npagroup.com.au
Related Story Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) as Perioperative Treatment for Adults With Cisplatin-Ineligible Resectable Muscle-Invasive Bladder Cancer

Associated Press
Related Story Perspective Therapeutics to Present Data from All Clinical Programs at the 2026 ASCO Annual Meeting, including Findings from [212Pb]VMT01 in Melanoma

GlobeNewswire